natgillin/translations-raw huggingface dataset:
When dexmedetomidine and butorphanol are used concomitantly in dogs bradypnoea, tachypnoea, an irregular respiratory pattern (20-30 sec apnoea followed by several rapid breaths), hypoxaemia, muscle twitch or tremor or paddling, excitation, hypersalivation, retching, vomiting, urination, skin erythema, a sudden arousal, or prolonged sedation may occur.
Pri sočasni uporabi deksmedetomidina in butorfanola se lahko pri psih pojavijo upočasnjeno ali pospešeno dihanje, nepravilni dihalni vzorci (20–30 sekund apneje, ki jim sledi nekaj hitrih vdihov), hipoksemija, trzanje mišic ali drhtenje ali brcanje, razdraženje, povečano izločanje sline, bljuvanje, bruhanje, uriniranje, kožni eritem, nenadno prebujanje ali dolgotrajna sedacija.
When dexmedetomidine and butorphanol are used concomitantly in dogs, bradypnoea, tachypnoea, an irregular respiratory pattern (20-30 sec apnoea followed by several rapid breaths), hypoxaemia, muscle twitch or tremor or paddling, excitation, hypersalivation, retching, vomiting, urination, skin erythema, a sudden arousal, or prolonged sedation may occur.
Pri sočasni uporabi deksmedetomidina in butorfanola se lahko pri psih pojavijo upočasnjeno ali pospešeno dihanje, nepravilni dihalni vzorci (20–30 sekund apneje, ki jim sledi nekaj hitrih vdihov), hipoksemija, trzanje mišic ali drhtenje ali brcanje, razdraženje, povečano izločanje sline, bljuvanje, bruhanje, uriniranje, kožni eritem, nenadno prebujanje ali dolgotrajna sedacija.
When dexmedetomidine and butorphanol are used concomitantly in dogs, bradypnoea, tachypnoea, an irregular respiratory pattern (20-30 sec apnoea followed by several rapid breaths), hypoxaemia, muscle twitch or tremor or paddling, excitation, hypersalivation, retching, vomiting, urination, skin erythema, a sudden arousal, or prolonged sedation may occur.
Pri sočasni uporabi deksmedetomidina in butorfanola se pri psih lahko pojavijo upočasnjeno ali pospešeno dihanje, nepravilni dihalni vzorci (20–30 sekund apneje, ki jim sledi nekaj hitrih vdihov), hipoksemija, trzanje mišic ali drhtenje ali brcanje, razdraženje, povečano izločanje sline, bljuvanje, bruhanje, uriniranje, kožni eritem, nenadno prebujanje ali dolgotrajna sedacija.
When dexmedetomidine is used as a premedicant in cats, vomiting, retching, pale mucous membranes, and low body temperature may occur.
Pri uporabi deksmedetomidina za premedikacijo mačk na kirurške posege lahko pride do bruhanja, poskusov bljuvanja, bledih mukoznih membran in nizke telesne temperature.
When dexmedetomidine is used as a premedicant in dogs bradypnoea, tachypnoea and vomiting may occur.
Pri uporabi deksmedetomidina za premedikacijo psov na kirurške posege lahko pride do bradipneje, tahipneje in bruhanja.
When dexmedetomidine is used as a premedicant in dogs, bradypnoea, tachypnoea and vomiting may occur.
Pri uporabi deksmedetomidina za pripravo na kirurške posege pri psih lahko pride do bradipneje, tahipneje in bruhanja.
When dexmedetomidine is used for premedication in cats, the same dose is used.
Pri uporabi deksmedetomidina za premedikacijo mačk na operacijo se uporablja isti odmerek.
When dexmedetomidine is used for premedication in cats, the same dose is used. .
Pri uporabi deksmedetomidina za pripravo mačk na operacijo se uporablja isti odmerek.
When diet and exercise alone do not provide adequate glycaemic control in patients for whom the use of metformin is considered inappropriate due to intolerance or contraindications.
Kadar dieta in telesna vadba sami ne zagotavljata zadostne glikemične urejenosti pri bolnikih, pri katerih se uporaba metformina šteje za neustrezno zaradi neprenašanja ali kontraindikacij.
When diet and exercise alone do not provide adequate glycaemic control in patients for whom use of metformin is considered inappropriate due to intolerance or contraindications.
Če samo dieta in telesna vadba ne zagotavljata ustrezne urejenosti glikemije pri bolnikih, pri katerih uporaba metformina zaradi intolerance ali kontraindikacij ni primerna.
When diluted Busilvex is a clear colourless solution.
Razredčeno zdravilo Busilvex je prozorna, brezbarvna raztopina.
When diluted Busulfan Fresenius Kabi is a clear colourless viscous solution.
Razredčeno zdravilo Busulfan Fresenius Kabi je bistra, brezbarvna, viskozna raztopina.
When diluted in 100 ml sodium chloride 9 mg/ml (0.9) the medicinal product contains 17.7 mmol (or 406 mg) sodium.
Pri redčenju s 100 ml natrijevega klorida 9 mg/ml (0,9 ) vsebuje zdravilo 17,7 mmol (ali 406 mg) natrija.
When diluted in 100 ml sodium chloride 9 mg/ml (0.9) this medicinal product contains 17.7 mmol (or 406 mg) sodium per dose.
Pri redčenju s 100 ml natrijevega klorida 9 mg/ml (0,9 ) vsebuje zdravilo 17,7 mmol (ali 406 mg) natrija na odmerek.
When diluted in 5% glucose, Accofil is compatible with glass and a variety of plastics including PVC, polyolefin (a co-polymer of polypropylene and polyethylene) and polypropylene.
Če je razredčeno s 5-odstotno raztopino glukoze, je zdravilo Accofil združljivo s steklom in različnimi plastičnimi materiali, vključno s PVC, poliolefinom (kopolimerom polipropilena in polietilena) in polipropilenom.
When diluted in 5% glucose, Grastofil is compatible with glass and a variety of plastics including PVC, polyolefin (a co-polymer of polypropylene and polyethylene) and polypropylene.
Če je razredčeno s 5-% raztopino glukoze, je zdravilo Grastofil kompatibilno s steklom in različnimi plastičnimi materiali, vključno s PVC, poliolefinom (kopolimerom polipropilena in polietilena) in polipropilenom.
When diluted in 5% glucose, Grastofil is compatible with glass and a variety of plastics including PVC, polyolefin (a co-polymer of polypropylene and polyethylene) and polypropylene.
Če je razredčeno s 5-% raztopino glukoze, je zdravilo Grastofil združljivo s steklom in različnimi plastičnimi materiali, vključno s PVC, poliolefinom (kopolimerom polipropilena in polietilena) in polipropilenom.
When diluted in 50 mg/ml (5%) glucose solution for infusion, filgrastim is compatible with glass and a variety of plastics including polyvinyl chloride (PVC), polyolefin (a co-polymer of polypropylene and polyethylene) and polypropylene.
Filgrastim, ki je razredčen s 50 mg/ml (5 %) raztopino glukoze za infundiranje, je kompatibilen s steklom in različnimi plastičnimi materiali, vključno s polivinilkloridom (PVC), poliolefinom (kopolimerom polipropilena in polietilena) in polipropilenom.
When diluted in glucose 50 mg/mL (5 %) solution for infusion, Biograstim is compatible with glass and a variety of plastics including PVC, polyolefin (a co-polymer of polypropylene and polyethylene) and polypropylene.
Če je razredčeno v glukozi 50 mg/ml (5%) raztopini za infundiranje, je zdravilo Biograstim kompatibilno s steklom in vrsto plastičnih snovi, med katerimi so PVC, poliolefin (kopolimer polipropilena in polietilena) in polipropilen.
When diluted in glucose 50 mg/mL (5 %) solution for infusion, Ratiograstim is compatible with glass and a variety of plastics including PVC, polyolefin (a co-polymer of polypropylene and polyethylene) and polypropylene.
Če je razredčeno v glukozi 50 mg/ml (5 %) raztopini za infundiranje, je zdravilo Ratiograstim kompatibilno s steklom in vrsto plastičnih snovi, med katerimi so PVC, poliolefin (kopolimer polipropilena in polietilena) in polipropilen.
When diluted in glucose 50 mg/mL (5 %) solution for infusion, Ratiograstim is compatible with glass and a variety of plastics including PVC, polyolefin (a co-polymer of polypropylene and polyethylene) and polypropylene.
Če je razredčeno v glukozi 50 mg/ml (5%) raztopini za infundiranje, je zdravilo Ratiograstim kompatibilno s steklom in vrsto plastičnih snovi, med katerimi so PVC, poliolefin (kopolimer polipropilena in polietilena) in polipropilen.
When diluted in glucose 50 mg/mL (5 %) solution for infusion, Tevagrastim is compatible with glass and a variety of plastics including PVC, polyolefin (a co-polymer of polypropylene and polyethylene) and polypropylene.
Če je razredčeno v glukozi 50 mg/ml (5 %) raztopini za infundiranje, je zdravilo Tevagrastim kompatibilno s steklom in vrsto plastičnih snovi, med katerimi so PVC, poliolefin (kopolimer polipropilena in polietilena) in polipropilen.
When diluted in glucose 50 mg/mL (5 %) solution for infusion, Tevagrastim is compatible with glass and a variety of plastics including PVC, polyolefin (a co-polymer of polypropylene and polyethylene) and polypropylene.
Če je razredčeno v glukozi 50 mg/ml (5%) raztopini za infundiranje, je zdravilo Tevagrastim kompatibilno s steklom in vrsto plastičnih snovi, med katerimi so PVC, poliolefin (kopolimer polipropilena in polietilena) in polipropilen.
When diluted in glucose 50 mg/ml (5%) solution for infusion, Nivestim is compatible with glass and a variety of plastics including PVC, polyolefin (a co-polymer of polypropylene and polyethylene) and polypropylene.
Če zdravilo Nivestim redčimo s 50 mg/ml (5 %) raztopino glukozo za infundiranje, je kompatibilno s steklom in različnimi plastičnimi materiali, vključno s PVC, poliolefinom (kopolimerom polipropilena in polietilena) in polipropilenom.
When diluted with 100 ml sodium chloride 9 mg/ml (0.9 %) solution for infusion, the initial rate will be 3 ml/hr.
Če je zdravilo razredčeno s 100 ml natrijevega klorida 9 mg/ml (0,9 %), mora biti začetna hitrost infundiranja 3 ml/uro.
When diluted with 250 ml sodium chloride 9 mg/ml (0.9 %) solution for infusion, the initial rate will be 6 ml/hr.
Če je zdravilo razredčeno z 250 ml natrijevega klorida 9 mg/ml (0,9 %), mora biti začetna hitrost infundiranja 6 ml/uro.
When diluted, the solution for infusion contains approximately 2.6 mg/ml of natalizumab.
Razredčena raztopina za infundiranje vsebuje približno 2,6 mg/ml natalizumaba.
When dinutuximab attaches to the gangliosides on neuroblastoma cells, it marks the cells out as targets for the immune system (the body’s natural defences), which then attacks them.
Ko se dinutuksimab veže na gangliozide na celicah nevroblastoma, celice označi kot tarče za imunski sistem (naravni obrambni sistem telesa), ki jih nato napade.
When disinfecting the neck of the ampoule with an antiseptic, to avoid any interaction with the Pedea solution, the ampoule must be completely dry before it is opened.
Da bi se izognili kakeršnikoli reakciji z raztopino zdravila Pedea, pri razkuževanju vrata ampule z antiseptikom, je treba zagotoviti, da je ampula popolnoma suha, preden jo odpremo.
When dissolved, drink entire contents
Popijte celotno vsebino raztopine.
When documented the temporal relationship between the event onset and the start of rivastigmine indicates a causal relationship.
V primerih z dokumentirano časovno povezanostjo med nastopom dogodka in začetkom jemanja rivastigmina, je ta kazala na vzročno povezanost rivastigmina z dogodki.
When dogs were treated there was reduced sperm development in the testes.
Ko so zdravili pse, so opazili zmanjšano nastajanje sperme v testisih.
When done, RELEASE your thumb, and gently lift the syringe off skin.
Ko ste opravili, ODMAKNITE palec in brizgo previdno dvignite od kože.
When dose reduction is necessary, the axitinib dose may be reduced to 3 mg twice daily and further to 2 mg twice daily.
Kadar je potrebno zmanjšanje odmerka, je odmerek aksitiniba mogoče zmanjšati na 3 mg dvakrat na dan in nadalje na mg dvakrat na dan.
When dose restarted decrease dose by one dose level.
Pri nadaljevanju odmerek zmanjšajte za eno raven.
When dosed in combination with the strong CYP3A inducer carbamazepine, the average t1/2 was 25 hours.
Pri dajanju v kombinaciji z močnim induktorjem CYP3A, karbamazepinom, je bil povprečni t1/2 25 ur.
When driving or using machines, it should be taken into account that dizziness has been reported in studies with saxagliptin.
V primeru vožnje ali upravljanja s stroji treba upoštevati, da je bila v študijah saksagliptina opisana omotica.
When driving vehicles or operating machinery it must be borne in mind that dizziness or drowsiness may occasionally occur when taking Rasilez HCT.
Treba je upoštevati, da lahko med jemanjem zdravila Rasilez HCT občasno pride do omotičnosti ali dremavosti.
When driving vehicles or operating machinery it should be taken into account that dizziness or drowsiness may occasionally occur when taking antihypertensive therapy such as Kinzalkomb.
Bolniki, ki vozijo motorna vozila ali upravljajo stroje, morajo upoštevati, da lahko antihipertenzivno zdravljenje, na primer z zdarvilom Kinzalkomb, včasih povzroči omotico ali dremavost.
When driving vehicles or operating machinery it should be taken into account that dizziness or drowsiness may occasionally occur when taking antihypertensive therapy such as Kinzalkomb.
Bolniki, ki vozijo motorna vozila ali upravljajo stroje, morajo upoštevati, da lahko antihipertenzivno zdravljenje, na primer z zdravilom Kinzalkomb, včasih povzroči omotico ali dremavost.
When driving vehicles or operating machinery it should be taken into account that dizziness or drowsiness may occasionally occur when taking antihypertensive therapy such as Kinzalmono.
Bolniki, ki vozijo motorna vozila ali upravljajo stroje, morajo upoštevati, da lahko antihipertenzivno zdravljenje, tudi z zdravilom Kinzalmono, včasih povzroči omotico ali dremavost.
When driving vehicles or operating machinery it should be taken into account that dizziness or drowsiness may occasionally occur when taking antihypertensive therapy such as Micardis.
Bolniki, ki vozijo motorna vozila ali upravljajo stroje, morajo upoštevati, da lahko antihipertenzivno zdravljenje, na primer z zdravilom Micardis, včasih povzroči omotico ali dremavost.
When driving vehicles or operating machinery it should be taken into account that dizziness or drowsiness may occasionally occur when taking antihypertensive therapy such as MicardisPlus.
Bolniki, ki vozijo motorna vozila ali upravljajo stroje, morajo upoštevati, da lahko antihipertenzivno zdravljenje, na primer z zdravilom MicardisPlus včasih povzroči omotico ali dremavost.
When driving vehicles or operating machinery it should be taken into account that dizziness or drowsiness may occasionally occur when taking antihypertensive therapy such as MicardisPlus.
Bolniki, ki vozijo motorna vozila ali upravljajo stroje, morajo upoštevati, da lahko antihipertenzivno zdravljenje, na primer z zdravilom MicardisPlus, včasih povzroči omotico ali dremavost.
When driving vehicles or operating machinery it should be taken into account that dizziness or drowsiness may occasionally occur when taking antihypertensive therapy such as PritorPlus.
Bolniki, ki vozijo motorna vozila ali upravljajo stroje, morajo upoštevati, da lahko antihipertenzivno zdravljenje, na primer z zdravilom PritorPlus, včasih povzroči omotico ali dremavost.
When driving vehicles or operating machinery it should be taken into account that dizziness or drowsiness may occasionally occur when taking antihypertensive therapy such as Telmisartan Actavis.
V zvezi z vožnjo ali upravljanjem s stroji je treba upoštevati, da se lahko med antihipertenzivnim zdravljenjem, na primer z zdravilom Telmisartan Actavis, občasno pojavi omotica ali zaspanost.
When driving vehicles or operating machinery it should be taken into account that dizziness or drowsiness may occasionally occur when taking antihypertensive therapy such as Telmisartan Teva.
Bolniki, ki vozijo motorna vozila ali upravljajo stroje, morajo upoštevati, da lahko antihipertenzivno zdravljenje, na primer z zdravilom Telmisartan Teva, včasih povzroči omotico ali dremavost.
When driving vehicles or operating machinery it should be taken into account that dizziness or drowsiness may occasionally occur when taking antihypertensive therapy such as Tolucombi.
Bolniki, ki vozijo motorna vozila ali upravljajo stroje, morajo upoštevati, da lahko antihipertenzivno zdravljenje, na primer z zdravilom Tolucombi, včasih povzroči omotico ali dremavost.
When driving vehicles or operating machinery it should be taken into account that dizziness or drowsiness may occasionally occur when undergoing antihypertensive therapy such as Actelsar HCT.
Bolniki, ki vozijo motorna vozila ali upravljajo stroje, morajo upoštevati, da lahko antihipertenzivno zdravljenje, na primer z zdravilom Actelsar HCT, včasih povzroči omotico ali dremavost.
When driving vehicles or using machines, it should be taken into account that dizziness may occur during treatment (see section 4.8).
Pri vožnji ali upravljanju s stroji je treba upoštevati, da se lahko med zdravljenjem pojavi omotica (glejte poglavje 4.8).
When Ebilfumin is used during a flu epidemic, this dose can be given for up to six weeks.
Kadar se zdravilo Ebilfumin uporablja med epidemijo gripe, se lahko tak odmerek daje do šest tednov.
When Ebymect is used with insulin, the doctor may need to lower the dose of insulin to reduce the risk of hypoglycaemia (low blood sugar levels).
Če se zdravilo Ebymect uporablja skupaj z insulinom, mora zdravnik včasih zmanjšati odmerek insulina, da se zmanjša tveganje za hipoglikemijo (nizke ravni sladkorja v krvi).
When Ecoporc Shiga is given to pigs, the animal’s immune system recognises the toxin contained in the vaccine as ‘foreign’ and makes antibodies against it.
Ko prašiči prejmejo cepivo Ecoporc Shiga, njihov imunski sistem prepozna toksin v cepivu kot tujek in začne proti njemu tvoriti protitelesa.
When Edistride was added to other diabetes medicines, Edistride 10 mg decreased HbA1c levels by 0.54-0.68% more than placebo after 24 weeks.
Pri uporabi 10-miligramskega odmerka zdravila Edistride v kombinaciji z drugimi zdravili proti sladkorni bolezni so se po 24 tednih ravni HbA1c zmanjšale za 0,54–0,68 % več kot pri placebu.
When efavirenz is
Pri sočasni uporabi efavirenza in
When efavirenz is co-
Pri sočasni uporabi efavirenza in
When efavirenz is co- administered with an anticonvulsant that is a substrate of CYP450 isoenzymes, periodic monitoring of anticonvulsant levels should be conducted.
Ob sočasni uporabi efavirenza in antikonvulziva, ki je substrat izoencimov CYP450, je treba periodično nadzorovati koncentracije antikonvulzivov.
When efavirenz was given with ritonavir 500 mg or 600 mg twice daily, the combination was not well tolerated (for example, dizziness, nausea, paraesthesia and elevated liver enzymes occurred).
Kadar so efavirenz dajali skupaj s 500 mg ali 600 mg ritonavirja dvakrat na dan, bolniki te kombinacije niso dobro prenašali (pojavili so se na primer omotica, navzea, parestezija in zvišane vrednosti jetrnih encimov).
When either valproate or lithium was administered concomitantly with aripiprazole, there was no clinically significant change in aripiprazole concentrations, and, therefore, no dose adjustment is necessary when either valproate or lithium is administered with Abilify Maintena.
Med sočasno uporabo litija ali valproata z aripiprazolom se koncentracija aripiprazola ni klinično pomembno spremenila, zato ob uporabi valproata ali litija z zdravilom Abilify Maintena ni potrebna prilagoditev odmerka.
When either valproate or lithium were administered concomitantly with aripiprazole, there was no clinically significant change in aripiprazole concentrations.
Med sočasno uporabo aripiprazola z litijem ali valproatom se koncentracija aripiprazola ni klinično pomembno spremenila.
When either Xeloda or 5-FU and folinic acid were taken with oxaliplatin, it took an average of eight months for the disease to get worse in patients who had not been treated before, and five months in patients whose previous treatment had failed.
Kadar je bilo bodisi zdravilo Xeloda bodisi 5-FU in folna kislina vzeto v kombinaciji z oksaliplatinom je pri bolnikih, ki pred tem še niso bili zdravljeni, trajalo v povprečju osem mesecev, da je bolezen napredovala, pri bolnikih, pri katerih predhodno zdravljenje ni bilo uspešno, pa je do napredovanja bolezni v povprečju prišlo v petih mesecih.
When elevations of either ALT or AST > 5 x ULN, or elevations in bilirubin > 3 x ULN were observed, abiraterone acetate was withheld or discontinued.
Ko je pri bolnikih prišlo do zvišanja koncentracije bodisi ALT ali AST na > 5-kratnik zgornje meje normalnih vrednosti ali do zvišanja koncentracije bilirubina na > 3-kratnik zgornje meje normalnih vrednosti, so zdravljenje z abirateronacetatom začasno ali dokončno prekinili.
When Eliquis is used for the treatment of deep vein thrombosis and pulmonary embolism and the prevention of their reoccurrence, the most common side effects are haemorrhage, haematoma, contusion, epistaxis, bleeding in the gut, rectum or gums, and haematuria (blood in the urine).
Kadar se zdravilo Eliquis uporablja za zdravljenje globoke venske tromboze in pljučne embolije ter za preprečevanje njunega ponovnega pojava, so najpogostejši neželeni učinki krvavitev, hematom, kontuzija, epistaksa, krvavitve v črevesju, danki ali dlesnih in hematurija (kri v urinu).
When eltrombopag is given in combination with antivirals reference should be made to the full summary of product characteristics of the respective coadministered medicinal products for comprehensive details of relevant safety information or contraindications.
Ko se eltrombopag uporablja v kombinaciji s protivirusnimi zdravili, je potrebno upoštevati celoten povzetek glavnih značilnosti sočasno uporabljenih zdravil za podrobnejše informacije o varnosti in kontraindikacijah.
When empagliflozin is used in combination with a sulphonylurea or with insulin, a lower dose of the sulphonylurea or insulin may be considered to reduce the risk of hypoglycaemia (see sections 4.5 and 4.8).
Če se empagliflozin uporablja v kombinaciji s sulfonilsečnino ali insulinom, bo morda potrebno zmanjšati odmerka sulfonilsečnine ali insulina, da bi zmanjšali tveganje hipoglikemije (glejte poglavji 4.5 in 4.8).
When Empliciti is given in combination with lenalidomide, you must follow the pregnancy prevention programme for lenalidomide (see package leaflet for lenalidomide).
Pri uporabi zdravila Empliciti v kombinaciji z lenalidomidom morate upoštevati navodila za preprečevanje nosečnosti pri uporabi lenalidomida (glejte navodila za uporabo lenalidomida).
When emtricitabine (one of the components of Eviplera) was administered to paediatric patients, the following adverse reactions were observed more frequently in addition to the adverse reactions reported in adults: anaemia was common (9.5%) and skin discolouration (increased pigmentation) was very common (31.8%) in paediatric patients (see section 4.8, Tabulated summary of adverse reactions).
Pri dajanju emtricitabina (ene od sestavin zdravila Eviplera) pediatričnim bolnikom so pogosteje opazili naslednje neželene učinke, poleg neželenih učinkov, o katerih so poročali pri odraslih: pri pediatričnih bolnikih je bila anemija pogosta (9,5 %) in sprememba obarvanosti kože (povečana pigmentacija) je bila zelo pogosta (31,8 %) (glejte poglavje 4.8, Povzetek neželenih učinkov, prikazan v preglednici).
When Equip WNV is given to horses, their immune system recognises the virus contained in the vaccine as ‘foreign’ and makes antibodies to defend against it.
Ko konji prejmejo cepivo Equip WNV, njihov imunski sistem prepozna virus v cepivu kot „tujek“ in začne proti njim tvoriti protitelesa.
When Eryseng is given to pigs the animals’ immune system recognises the bacteria as ‘foreign’ and makes antibodies against them.
Ko prašiče cepimo z zdravilom Eryseng, njihov imunski sistem bakterije prepozna kot „tujke“ in proti njim razvije protitelesa.
When Eryseng Parvo is given to pigs the animals’ immune system recognises the virus and bacteria as ‘foreign’ and makes antibodies against them.
Ko prašiče cepimo z zdravilom Eryseng Parvo, njihov imunski sistem virus in bakterije prepozna kot „tujke“ in proti njim razvije protitelesa.
When Eucreas is used in combination with a sulphonylurea, a lower dose of the sulphonylurea may be considered to reduce the risk of hypoglycaemia.
Kadar bolnik jemlje zdravilo Eucreas v kombinaciji s sulfonilureo, je treba razmisliti o nižjem odmerku sulfoniluree, da bi zmanjšali tveganje za hipoglikemijo.
When Evalon is given to chickens, the animals’ immune system recognises the Eimeria oocysts as foreign and makes defences against them.
Ko piščanci prejmejo zdravilo Evalon, imunski sistem živali prepozna oociste vrste Eimeria kot „tujek“ ter začne proti njim tvoriti protitelesa.